Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Cellular Biomedicine Group Announces Proposed Follow-on Offering of Common Stock
-
Cellular Biomedicine Group to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Cellular Biomedicine Group to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Cellular Biomedicine Group (CBMG) Reports $30.6M Investment from Sailing Capital Overseas Investment Ltd.
-
Cellular Biomedicine Group Announces $30.6 million Investment from Sailing Capital Overseas Investment Ltd.
-
Cellular Biomedicine Group Announces $30.6 million Investment from Sailing Capital Overseas Investment Ltd.
-
Cellular Biomedicine Group to Present at the Cantor Fitzgerald Global Healthcare Conference

